ATP6V1F and hepatocellular carcinoma: We investigated the association of ATP6V1F with immune cell infiltration in HCC and coexpression of ATP6V1F with immune checkpoints, confirming the potential of ATP6V1F as a marker for immunotherapeutic stratification and a target for immunotherapy.